Deliberate release into the
environment of GMOs for any other purposes than placing on the
market:
Testing of 1507 maize varieties -
Pioneer Génétique Sarl |
Date of publication: January 27,
2005
Source:
http://gmoinfo.jrc.it/gmp_browse_geninf.asp
Notification
report
General information
Notification Number: B/FR/05/01.02
Member State: France
Date of Acknowledgement:10/12/2004
Title of the Project: Testing of 1507 maize varieties
Proposed period of release From:01/04/2005
To:31/12/2008
Name of the Institute(s) or Company(ies): Pioneer
Genetique Sarl;
3. Is the same GMPt release planned elsewhere in the
Community?
No
4 - Has the same GMPt been notified elsewhere by the same
notifier?
No
Genetically
modified plant
1. Complete name of the
recipient or parental plant(s)
|
Common Name
|
Family Name
|
Genus |
Species
|
Subspecies
|
Cultivar/breeding line
|
| maize
|
poaceae |
zea
|
zea
mays |
mays
|
experimental varieties |
2. Description of the traits and characteristics which have
been introduced or modified, including marker genes and previous
modifications:
New genes were introduced into the genetically modified maize
plants so that they can fight against the damages caused by
certain Lepidopteran insect pests, such as European Corn Borer
(Ostrinia nubilalis), and tolerate application of
glufosinate-ammonium herbicide for the weeding of maize crop.
Genetic
modification
3. Type of genetic
modification:
Insertion;
4. In case of insertion of genetic material, give the source
and intended function of each constituent fragment of the region
to be inserted:
The introduced genes are the cry1F gene from Bacillus
thuringiensis var. aizawai, providing resistance to certain
Lepidopteran insects and the pat gene from Streptomyces
viridochromogenes providing tolerance to glufosinate-ammonium
herbicide, along with their regulatory components necessary for
expression in maize plant:
- The cry1F gene, the UBIZM1(2) promoter, the ORF25PolyA
terminator.
- The pat gene, the CaMV35S promoter, the CaMV35S terminator.
6. Brief description of the method used for the genetic
modification:
The genetic modification has been done by the particle
acceleration method using a "gene gun" to introduce, into maize
cells, a linear DNA fragment containing the two genes along with
their regulatory components necessary for expression.
7. If the recipient or parental plant is a forest tree
species, describe ways and extent of dissemination and specific
factors affecting dissemination:
Not applicable.
Experimental
Release
1. Purpose of the release:
Several types of trials will be carried out, to collect data
on the agronomic value and insect resistance of 1507 maize
varieties and to observe the plant behavior, which could enable
to collect morpho-physiological data.
2. Geographical location of the site:
The releases are planned at several locations in France
within the following areas: Aquitaine (Landes, Lot et Garonne),
Centre (Eure et Loir, Loir et Cher, Indre, Indre et Loire,
Loiret), Midi-Pyrénées (Haute-Garonne, Gers, Tarn, Tarn et
Garonne), Languedoc-Roussillon (Aude).
3. Size of the site (m2):
Each year, there could be up to 10 sites, each sown with up
to 5000 m² of genetically modified maize subject of this
notification (1507 maize), the total trial surface for each site
(including all varieties and borders) being larger.
4. Relevant data regarding previous releases carried out with
the same GM-plant, if any, specifically related to the potential
environmental and human health impacts from the release:
Since 1996, field trials have already been conducted in
several locations with this genetically modified maize and no
environmental problems were reported for these trials. The
transgenic plants behaved as conventional maize. They were
indistinguishable from the non-genetically modified maize plants
except for being insect resistant and herbicide tolerant, traits
due to the genetic modification.
A dossier for importing 1507 maize in Europe was submitted to
the Competent Authority in the Netherlands in 2000 (Notification
C/NL/00/10). In 2001, a novel food notification was also
submitted to the Netherlands and the cultivation dossier of 1507
maize was submitted to Spain (Notification C/ES/01/01).
Environmental
Impact and Risk Management
Summary of the potential
environmental impact from the release of the GMPts:
No risks to human and animal health or the environment from
the deliberate release of genetically modified maize resistant
to certain Lepidopteran insects and tolerant to glufosinate
herbicide are expected, as per information contained in the
environmental risk assessment included in the notification.
Brief description of any measures taken for the management of
risks:
The shedding of pollen from the genetically modified plants
will be controlled by maintaining a 200-meter isolation distance
with any other non-experimental maize crop. In addition, the
trial site will be surrounded by four border rows of
conventional maize of a similar relative maturity that will be
also destroyed at the end of the release.
Seed dispersal of individual kernels does not generally occur.
They are fixed on a cob and enclosed in many husks that protect
the seeds from outside contact. When a few seeds need to be
collected for analysis; this will be done by sampling the whole
ear and unused seeds will be destroyed.
In case of any emergency, the trial could be stopped by
application of a non-selective herbicide other than glufosinate
or by mechanical destruction, and incorporation into the soil.
At the end of the release, all remaining plant matter that has
not been harvested for analyses will be destroyed by chopping
and incorporating into the soil.
Volunteer maize will be monitored during the following year. An
herbicide treatment (other than glufosinate) will be used in
order to ensure destruction if needed.
No commercial maize will be cultivated in the trial site the
following year.
Summary of foreseen field trial studies focused to gain new
data on environmental and human health impact from the release:
Not applicable to this release. |
|
|
|
